Literature DB >> 16372055

Angelman syndrome: need for further illumination in the theater of the happy puppet.

Raman Sankar.   

Abstract

Entities:  

Year:  2005        PMID： 16372055      PMCID： PMC1312737          DOI： 10.1111/j.1535-7511.2005.00069.x

Source DB:  PubMed          Journal:  Epilepsy Curr        ISSN： 1535-7511            Impact factor:   7.500


× No keyword cloud information.
  15 in total

1.  Levetiracetam reduces spike-wave density and duration during continuous EEG monitoring in patients with idiopathic generalized epilepsy.

Authors:  Martin J Gallagher; Lawrence N Eisenman; Kelly M Brown; Ebru Erbayat-Altay; Hrvoje Hecimovic; A James Fessler; Hrayr P Attarian; Frank G Gilliam
Journal:  Epilepsia       Date:  2004-01       Impact factor: 5.864

2.  Developmental profile of GABAA-receptors in the marmoset monkey: expression of distinct subtypes in pre- and postnatal brain.

Authors:  J P Hornung; J M Fritschy
Journal:  J Comp Neurol       Date:  1996-04-08       Impact factor: 3.215

3.  Subcellular localization of gamma-aminobutyric acid type A receptors is determined by receptor beta subunits.

Authors:  C N Connolly; J R Wooltorton; T G Smart; S J Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

4.  Functional properties of recombinant GABA(A) receptors composed of single or multiple beta subunit subtypes.

Authors:  J L Fisher; R L Macdonald
Journal:  Neuropharmacology       Date:  1997 Nov-Dec       Impact factor: 5.250

5.  Effects of levetiracetam, a novel antiepileptic drug, on convulsant activity in two genetic rat models of epilepsy.

Authors:  A J Gower; E Hirsch; A Boehrer; M Noyer; C Marescaux
Journal:  Epilepsy Res       Date:  1995-11       Impact factor: 3.045

6.  GABAA receptor beta3 subunit gene-deficient heterozygous mice show parent-of-origin and gender-related differences in beta3 subunit levels, EEG, and behavior.

Authors:  Patricia Liljelund; Adrian Handforth; Gregg E Homanics; Richard W Olsen
Journal:  Brain Res Dev Brain Res       Date:  2005-06-30

7.  Analysis of the characteristics of epilepsy in 37 patients with the molecular diagnosis of Angelman syndrome.

Authors:  Marta Galván-Manso; Jaume Campistol; Joan Conill; Francesc-Xavier Sanmartí
Journal:  Epileptic Disord       Date:  2005-03       Impact factor: 1.819

8.  Mice lacking the beta3 subunit of the GABAA receptor have the epilepsy phenotype and many of the behavioral characteristics of Angelman syndrome.

Authors:  T M DeLorey; A Handforth; S G Anagnostaras; G E Homanics; B A Minassian; A Asatourian; M S Fanselow; A Delgado-Escueta; G D Ellison; R W Olsen
Journal:  J Neurosci       Date:  1998-10-15       Impact factor: 6.167

9.  The synaptic vesicle protein SV2A is the binding site for the antiepileptic drug levetiracetam.

Authors:  Berkley A Lynch; Nathalie Lambeng; Karl Nocka; Patricia Kensel-Hammes; Sandra M Bajjalieh; Alain Matagne; Bruno Fuks
Journal:  Proc Natl Acad Sci U S A       Date:  2004-06-21       Impact factor: 11.205

10.  Levetiracetam in progressive myoclonic epilepsy: an exploratory study in 9 patients.

Authors:  C Crest; S Dupont; E Leguern; C Adam; M Baulac
Journal:  Neurology       Date:  2004-02-24       Impact factor: 9.910
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.